News


All series


All News

Imagine a meeting in which most of the great minds in your desired area of the profession of optometry come together to share their knowledge to build the greater worldwide profession. For me and the 300-plus attendees of the International Congress of Behavioural Optometry (ICBO), it is a dream come true.

During the American Academy of Optometry's Academy 2014, leading researchers and clinicians detailed the latest knowledge regarding the origins of and treatments for keratoconus.

During the American Academy of Optometry's Academy 2014, Leonid Skorin, Jr., OD, DO, MS, described a visual variant of Alzheimer's disease (AD) that may put optometrists on the front lines of this illness.

During the American Academy of Optometry’s Academy 2014, Hector C. Santiago, OD, PhD, dean of the college of optometry at the Inter-American University of Puerto Rico, said he believes cultural competence “will drive success in the new face of America.”

During the American Academy of Optometry's Academy 2014, presenters shared how optometrists can help halt the diabetes epidemic and combat associated ocular complications.

During the American Academy of Optometry's Academy 2014, Josh Johnston, OD, clinical director, Georgia Eye Partners, Atlanta, presented five pearls for successfully comanaging premium intraocular lens (IOL) patients.

Rachel Coulter, OD, FAAO, and Erin Jenewein, OD, FAAO, recently gave a presentation at the American Academy of Optometry's Academy 2014 meeting in Denver, CO, on recognizing ocular disease in children.

Glen Steele, OD, FAAO, recently gave a presentation at the American Academy of Optometry's Academy 2014 in Denver, CO, on the questions to ask and tests to conduct when considering vision therapy for a patient.

During the American Academy of Optometry's Academy 2014, concussion experts discussed the need for-and progress toward-user-friendly diagnostic tools for protecting athletes of all ages, and the key role of visual testing therein.

COPE makes CE easy

Recently, I had the opportunity to attend the Georgia Optometric Association’s annual fall meeting in Athens, GA. It is a pilgrimage I try to make each year to renew old acquaintances as well as get those required continuing education hours all ODs work for to keep our license current.

Researchers from the University of California, San Francisco, found that all three of the Google Glass wearers tested had blind spots in the upper right quadrant of the visual field, according to a study published in JAMA.

Denver-Before we head out to Denver for the American Academy of Optometry 2014 meeting, we asked our friends at Denver.com for some recommendations for the best spots to eat near the Colorado Convention Center. Writers Courtney Gibb and John Helkenn hand picked a list for Optometry Times with a little something for everybody that has us hungry already.

Alcon recently joined the Think About Your Eyes national public awareness campaign presented by The Vision Council and the American Optometric Association aimed at educating consumers on the benefits of vision health.

Johnson & Johnson recently announced the initial launch of 1-Day Acuvue Define contact lenses with Lacreon technology, a lens that will accentuate the eye’s natural beauty while helping to support eye health, according to the company.

Your patients may have seen wife of rapper T.I. and reality star Tameka “Tiny” Harris appear on Good Morning America this week to reveal she had undergone surgery to permanently change her brown eyes to “ice gray,” sparking a national conversation about the safety of such a procedure.

Bausch + Lomb recently announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo in eliminating inflammation and pain following cataract surgery by study Day 8, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

A recent study published in the Journal of Glaucoma found that there was no detected increase in glaucoma risk with current, recent, or past use of systemic fluoroquinolones, but did find a minimal statistically significant increased risk with distant use.

For any treatment to be successful, early detection is key. For that reason, genetic testing may play a role in determining the frequency of follow-up in patients who are determined to have high-risk alleles.

Q&A: Devin Sasser

I grew up in a small town called Mesquite, TX, right on the edge of Dallas, a small suburb. Texas weather is very temperamental (no pun intended), so there are days when it’s really cool. Real cool to me is about 50°F. [Laughs] Oh man, it’s cold outside, and then the next day it’s 80°F. I’m used to living in that range. And St. Louis, we have a winter here…but something about last year’s. It never went away.

I'm sure all of us have had days like this, or months like this, or even years like this, what I like to call, “Patients say the darndest things." See if any of these encounters sound familiar.

Abbott recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two new products used in laser cataract surgery, the Cataract Operating System 3 (cOS3) and the Liquid Optics Interface 12, both for the company’s Catalys Precision Laser System.

The U.S. Food and Drug Administration approved VisionCare Ophthalmic Technologies’ implantable miniature telescope for use in patients living with bilateral end-stage age-related macular degeneration (AMD) who are age 65 or older.